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The options available to treat pediatric air-
way obstruction include surgical resection
and anastomosis (including slide tracheo-
plasty), silicone (eg, Dumon) stents, Mont-
gomery T-tubes, and SEMS. Recently, there
has been a disturbing trend of using SEMS
as the first option in treating benign tracheo-
bronchial pathology, primarily because of
the ease of deployment and the dramatic
relief of obstruction in the short term.2 We
feel that it needs to be reiterated strongly
that SEMS should remain the last resort in
patients with benign stenosis or those with
a surgically correctable airway obstruction.
SEMS have a number of complications that
are difficult to treat long-term. The ideal
indication for SEMS is a patient with ter-
minal malignancy with airway obstruction
in whom the expected low survival from
the primary malignancy precludes the oc-
currence of stent-related complications.
SEMS cause intense granulation tissue,
which often causes the same symptoms for
which the stent was deployed; subsequent
attempts to alleviate this problem with la-
ser, electrocautery, and so on usually have
disappointing results. Moreover, contrary
to the authors’ views, removal of these
stents is difficult and fraught with danger.
Single and short-segment tracheal stenosis
should be treated by primary surgery in
centers experienced in pediatric tracheal
surgery. Stenting should be reserved for
patients in an acute situation (where sili-
cone stents may be deployed as a tempo-
rary measure) before referral to a center
specializing in tracheal surgery.
Although not practical in infants and
very small children, Dumon stents and
Montgomery T-tubes are invaluable in
stenting lesions that are too long for safe
reconstruction.3 More often than not, the
stent stabilizes the airway, and decannula-
tion is possible in most cases.4 Moreover,
the ease with which silicon stents can be
removed if definitive surgery is being con-
sidered makes it an attractive option to tide
over an acute situation. The pediatrician,
pulmonologist, or thoracic surgeon in-
volved in managing complex airway prob-
lems needs to be aware of the basic under-
lying pathology and intelligently apply the
right solution to a specific problem.
C. S. Pramesh, MS, FRCS
Rajesh C. Mistry, MS




1. Vinograd I, Keidar S, Weinberg M, Silbiger
A. Treatment of airway obstruction by metal-
lic stents in infants and children. J Thorac
Cardiovasc Surg. 2005;130:146-50.
2. Wood DE, Liu YH, Vallieres E, Karmy-Jones
R, Mulligan MS. Airway stenting for malig-
nant and benign tracheobronchial stenosis.
Ann Thorac Surg. 2003;76:167-74.
3. Grillo HC. Stents and sense. Ann Thorac Surg.
2000;70:1142.
4. Pereszlenyi A, Igaz M, Majer I, Harustiak S.
Role of endotracheal stenting in tracheal re-
construction surgery—retrospective analysis.
Eur J Cardiothorac Surg. 2004;25:1059-64.
doi:10.1016/j.jtcvs.2005.08.025
Reply to the Editor:
In my article I emphasized that the use of
intratracheal stents in children is dangerous
and carries the risk of severe complications.
With regard to the use of self-expandable
metallic stents (SEMS), I completely agree
that their use should be avoided. There are
enough data in the literature to support
this.1 The SEMS in this study were made
from nitinol, an alloy with a “shape mem-
ory effect.” In animal studies, this stent,
because of its unique biochemical property,
could he fixed and removed easily, even in
very small airways.2 In children, their use
was associated with an excessive granula-
tion, and although the extraction proved to
be easy and smooth, their application is
currently suspended.
Currently available silicone or Dumoan
stents have an external diameter that pre-
vents their use in infants and small chil-
dren.
The Montgomery and I-tubes could be
an option in tracheal strictures, but they are
not practical in bronchial or distal airway
problems.
I would like to thank Mr Pramesh for
his remarks.
Itzhak Vinograd, MD
Department of Pediatric Surgery
DANA Children’s Hospital
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Molecular changes occurring with
aneurysm formation: Possible impact
of sampling error
To the Editor:
We congratulate Cotrufo and colleagues1
for exploring messenger RNA expression
and extracellular matrix protein content
in the ascending aorta associated with
bicuspid aortic valves (BAVs), with par-
ticular attention to differences between
the inner and outer curvatures. Our lab-
oratory is also exploring the molecular
changes occurring with aneurysm forma-
tion, and we have been concerned about
the potential impact of sampling error on
experimental results.
Cotrufo and colleagues1 demonstrated dif-
ferences in levels of collagens I, III, and IV, as
well as fibronectin and laminin protein, by
western blot analysis when comparing samples
taken from the concave and convex portions of
dilated aortas resected from patients with BAV.
Additionally, they reported differences between
patients with functionally regurgitant versus ste-
notic valves. Importantly, Cotrufo and col-
leagues1 also reported significant differences in
protein levels between dilated aortas (regardless
of functional valve pathology) and normal con-
trol aortas. Indeed, these differences were as
striking as those observed between concavity
and convexity or between stenotic and regurgi-
tant specimens.
We too are intrigued by the observations
made on aneurysmal tissues, but we urge
caution in interpreting the comparisons made
between dilated aortas and the control group.
A marked difference in age may have pro-
foundly impacted results. Cotrufo and col-
leagues1 reported mean ages for the regurgi-
tation, stenosis, and control groups as 56 9,
59 12, and 33 8 years, respectively. The
95% confidence intervals for these groups
(from data provided in the article’s on-line
Table E11) were 51.2-61.4, 50.9-66.4, and
24.6-41.4 years, respectively. The difference
in collagen expression led Cotrufo and col-
leagues1 conclude that “collagen degradation
by proteinases could prevail over collagen
synthesis” and that smooth muscle cells
“could react differently to different types and
degrees of mechanical stress and could favor,
in turn, a predominant production of either
ECM [extracellular matrix] proteins or pro-
teolytic enzymes.” An alternative hypothesis
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is that age-related changes explain these dif-
ferences. A proportional decrease in aortic
collagen with advancing age has been previ-
ously described.2 In our laboratory, we have
looked at messenger RNA expression in di-
lated aortas with microarray gene chip anal-
ysis. Looking at expression of tenascin, for
example, we have found similar expressions
in tissues from patients with aneurysms and
older control subjects (mean ages 63.3 6.4
years, 95% confidence interval 59.8-66.9
years, and 48.8 4.9 years, 95% confidence
interval 35.3-62.3 years, respectively). We
too have struggled to obtain appropriately
age-matched control tissue for obvious rea-
sons; however, appreciation of these age-re-
lated changes may be crucial to understand-
ing the pathophysiology and genetic basis of
BAV and aortic aneurysms and should not be
overlooked.
Again, Cotrufo and colleagues are to be
commended for their comparative study of
expression of extracellular matrix proteins
within dilated aortas among patients with
BAV. Their comparisons between regurgi-
tant and stenotic BAV and between the
concavity and convexity of dilated aortas
are valuable contributions to the field and
should be in the foreground of discussions,
whereas the comparisons between patients
with disease and control subjects should
remain in the background.
Stephen H. McKellar, MD
Sami Takieddine, MD
Ramanath Majumdar, PhD
Thoralf M. Sundt III, MD
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Mayo Clinic
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Rochester, MN 55905
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Reply to the Editor:
We appreciate the comments made by
McKellar and colleagues regarding our
study on extracellular matrix (ECM) pro-
teins in the dilated ascending aorta of
patients with bicuspid aortic valve
(BAV) disease.1 We agree with their
words of caution about the comparison
between patients and control subjects un-
matched for age. Unfortunately, the only
setting in which we could obtain normal
aortic tissue was multiorgan harvesting,
and heart donors are usually younger
than patients with aortic aneurysms.
Scarce information is available con-
cerning age-related changes in aortic
ECM composition in healthy subjects: in
rats, the collagen amount per square mil-
limeter decreases with age,2 and simi-
larly in human aortas, according to the
study of Cattell and associates3 cited by
McKellar and colleagues,3 the collagen
amount per sample (in this case the
amount in a tissue surface area 1 cm in
diameter) decreased by 80% between the
ages of 14 and 90 years. However, both
in rats3 and in human beings,4 the con-
centration of collagen—that is, the
amount per unit of tissue mass—in-
creases with age, because of a predomi-
nant loss of other media constituents. In
our study, as acknowledged in the Meth-
ods section,1 the presence of collagen in
both normal and diseased aortas was not
quantified as amount per sample, which
could have been affected by the differ-
ences in specimen thickness between dis-
eased (thinner wall) and normal vessel,
but in terms of the amount of collagen
separated from a constant mass of total
proteins. Therefore the difference in col-
lagen between patients with BAV and
control subjects could have been rather
reduced than emphasized by a possible
interference of age. Nevertheless, the ac-
tual impact of age differences cannot be
discerned, and we are trying in our on-
going research to obtain study groups as
properly matched for age as possible.
Indeed, our suggestion that the syn-
thesis and degradation of each ECM pro-
tein may be differently regulated by dif-
ferent types and degrees of rheologic and
mechanical disturbances1 was derived
from the comparison between patients
with stenotic and regurgitant BAVs (with
comparable mean ages) and not that be-
tween patients and control subjects. Our
most important finding, as recognized by
McKellar and colleagues, was the differ-
ent expressions of ECM proteins in the
convexity and the concavity of dilated
aortas, with typical signs of the “flow-
induced vascular remodeling” process
prevailing at the convexity. If further
confirmed, this evidence could exclude
that a congenital defect of some wall
component may be the prime mover for
aortic dilation in BAV disease, because a
genetic disorder capable in itself of caus-
ing dilatation should be equally ex-
pressed along the circumference of a
given tract of the vessel. On the contrary,
wall stress, which is known to promote
vascular remodeling,1 has been found to
unevenly involve the vessel when the
valve is bicuspid, with maximal burden at
the convex aspect of the ascending tract.5
Alessandro Della Corte, MD
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